Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
BrainStorm Cell Therapeutics has selected Worldwide Clinical Trials as its Clinical Research Organization for its planned Phase 3 study of NurOwn in the treatment of ALS.
read more
Exscientia has entered into a strategic drug discovery collaboration with GlaxoSmithKline.
read more
Imanova has signed an agreement that grants the company the right to manufacture for distribution and on-site use [18F]MK-6240, an early stage investigational PET imaging agent.
read more
AgeneBio announced that the company has received an additional $750,000 grant from the Alzheimer's Drug Discovery Foundation.
read more
A CDMO has expanded its GMP manufacturing offering with the installation of new automatic capsule filling capabilities at its EU-GMP approved plant in Spain.
read more
QuintilesIMS announced the general availability of a new category of pharmaceuticals commercial operations SaaS software called Orchestrated Customer Engagement (OCE) in the winter of 2017.
read more
Breckenridge announced it has entered into a multi-product agreement with Sam Chun Dang Pharm, under which Breckenridge and SCD expect to develop and commercialize at least seven ANDAs.
read more
Patheon announced it expects to invest approximately $45 million at key sites across its global network to meet growing customer demand for expanded service capabilities.
read more
CordenPharma and GE Healthcare’s Dharmacon business have entered a collaboration to create an end-to-end solution for oligonucleotide-based drug discovery.
read more
Takeda Pharmaceutical and Seattle Genetics announced the Phase 3 ECHELON-1 clinical trial met its primary endpoint of a statistically significant improvement in modified PFS versus the control arm.
read more
Recursion Pharmaceuticals announced it has hired Dr. Chand Sishta as the senior director of regulatory affairs.
read more
Research and Markets has announced the addition of the "Pharmaceutical Contract Manufacturing & Contract Research Market, 2014 - 2025" report to their offering.
read more
Heptares Therapeutics announced the launch of a new research collaboration under its ORBIT initiative with New York University School of Medicine.
read more
PerkinElmer announced the publication of the Fetal Medicine Foundation’s Project “ASPRE” study results in The New England Journal of Medicine.
read more
Professor Matthew Disney of TSRI, scientists from Mayo Clinic’s Florida campus and Johns Hopkins School of Medicine, have been awarded $7.2 million for the most common form of ALS and FTD.
read more